Dr. Martens plc
DOCMF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $504,276 | $861,856 | $1,476,230 | $2,458,567 |
| - Cash | $155,900 | $111,100 | $157,500 | $228,000 |
| + Debt | $404,100 | $477,000 | $445,800 | $393,800 |
| Enterprise Value | $752,476 | $1,227,756 | $1,764,530 | $2,624,367 |
| Revenue | $787,600 | $877,100 | $1,000,300 | $908,300 |
| % Growth | -10.2% | -12.3% | 10.1% | – |
| Gross Profit | $511,700 | $502,900 | $563,900 | $542,100 |
| % Margin | 65% | 57.3% | 56.4% | 59.7% |
| EBITDA | $110,500 | $196,300 | $204,400 | $266,000 |
| % Margin | 14% | 22.4% | 20.4% | 29.3% |
| Net Income | $4,500 | $69,200 | $128,900 | $181,200 |
| % Margin | 0.6% | 7.9% | 12.9% | 19.9% |
| EPS Diluted | 0.005 | 0.07 | 0.13 | 0.18 |
| % Growth | -92.9% | -46% | -27.8% | – |
| Operating Cash Flow | $196,300 | $167,900 | $71,700 | $173,600 |
| Capital Expenditures | -$18,700 | -$28,400 | -$51,400 | -$25,000 |
| Free Cash Flow | $177,600 | $139,500 | $20,300 | $148,600 |